Week of February 22, 2025: How GLP-1 meds, billing strategies, and EHRs impact your practice

This week, discover how to turn growing patient interest in GLP-1 medications into a revenue opportunity — while preparing for potential Medicare coverage expansion in 2026. 

For nurse practitioners, we’re covering key steps to launch your own practice and implement an EHR system that boosts efficiency and enhances patient care.

Plus, get strong denial management strategies to mitigate risk with ACA Marketplace plans, and stay informed on how recent healthcare policy changes could impact your practice.

New weight-loss drugs like Ozempic and Wegovy are changing how some people approach their health and wellness goals. Tebra surveyed over 1,000 Americans to understand the impact of GLP-1 medications on health priorities, self-image, and access. The findings highlight growing demand, affordability concerns, and shifting perceptions as these drugs shape wellness strategies for 2025. Here’s what you need to know as an independent provider.

Thank you for reading The Intake. As always, if you have questions or suggestions for future topics, please don't hesitate to drop a line at [email protected].